Olbas Pastilles

Страна: Мальта

Язык: английский

Источник: Medicines Authority

Активный ингредиент:

PEPPERMINT OIL, EUCALYPTUS OIL, CLOVE OIL, METHYL SALICYLATE, JUNIPER BERRY, LEVOMENTHOL

Доступна с:

G. R. Lane Health Products Limited Sisson Road, Gloucester, GL2 0GR, United Kingdom

код АТС:

R05X

ИНН (Международная Имя):

PEPPERMINT OIL 19 mg EUCALYPTUS OIL 19.7 mg CLOVE OIL 0.034 mg METHYL SALICYLATE 0.8 mg JUNIPER BERRY OIL 1.14 mg LEVOMENTHOL 1.7 mg

Фармацевтическая форма:

PASTILLE

состав:

PEPPERMINT OIL 19 mg EUCALYPTUS OIL 19.7 mg CLOVE OIL 0.034 mg METHYL SALICYLATE 0.8 mg JUNIPER BERRY OIL 1.14 mg LEVOMENTHOL 1.7 mg

Тип рецепта:

OTC

Терапевтические области:

COUGH AND COLD PREPARATIONS

Статус Авторизация:

Withdrawn

Дата Авторизация:

2005-12-23

тонкая брошюра

DO NOT USE IF SEALED INNER POUCH IS CUT OR TORN.
THE PURE NATURAL REMEDY
FOR SYMPTOMATIC RELIEF OF
COLDS, COUGHS, CATARRH,
SORE THROATS AND FLU,
CATARRHAL HEADACHE 
AND NASAL CONGESTION.
OLBAS PASTILLES CONTAIN
ESSENTIAL OILS WHICH HAVE
DECONGESTANT PROPERTIES.
ACTIVE INGREDIENTS 
PER PASTILLE:
Eucalyptus Oil ........ 19.7mg
Peppermint Oil....... 19.0mg
Levomenthol ............ 1.7mg
Juniper Oil ............. 1.14mg
Methyl Salicylate ..... 0.8mg
Clove Oil................. 0.03mg
OTHER INGREDIENTS: 
Modified Starch, Sucrose, 
Glucose, Sodium Copper 
Chlorophyllin (E141).
Manufactured by 
Ernest Jackson & Co. Ltd., 
Crediton, Devon, EX17 3AP, 
UK, for the Marketing 
Authorisation holder 
G. R. Lane Health Products 
Ltd., Sisson Road, Gloucester, 
GL2 0GR, UK, to whom any 
letters should be addressed.
Approved May 2008
PL 01074/0001
BEFORE YOU TAKE OLBAS PASTILLES
Do not take if you are allergic to any of the ingredients.
Taking other medicines Please tell your doctor or pharmacist 
if you are taking or have recently taken any other medicines, 
including medicines obtained without a prescription.
Pregnancy and breast-feeding It is best not to take any 
non-essential medication when pregnant or breast-feeding. Ask 
your doctor or pharmacist for advice before taking any medicine.
Important information about some of the ingredients of Olbas 
Pastilles If you have been told by your doctor that you have an 
intolerance to some sugars, contact your doctor before taking 
this medicinal product. This product contains 677mg of sucrose 
per pastille. This should be taken into account in people with 
diabetes mellitus.
HOW TO TAKE OLBAS PASTILLES
Adults and children aged 7 and over: Dissolve 1 pastille slowly 
in the mouth when required. Do not take more than 8 pastilles in 
any 24 hour period. Not recommended for children under 7 years 
old. You must contact a doctor if symptoms worsen or do not 
improve after 7 days.
If you take more Olbas Pastilles than you shou

Характеристики продукта

 
Page 1 of 5 
SUMMARY OF PRODUCT CHARACTERISTICS 

1. 
NAME OF THE MEDICINAL PRODUCT 

Olbas Pastilles 

2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 

Ingredients %w/w 
mg per pastille 
Eucalyptus Oil 
1.160 
19.70 
Peppermint Oil 
1.120 
19.00 
Levomenthol 0.100 
1.70 
Juniper Oil 
0.067 
1.14 
Methyl Salicylate 
0.047 
0.80 
Clove Oil 
0.002 
0.03 

Excipients: Glucose, Sucrose. 

For a full list of excipients, see section 6.1. 

3. PHARMACEUTICAL 
FORM 

Pastille. 
Dull green, oval ribbed, sugar-coated pastille. 

4. CLINICAL 
PARTICULARS 
4.1 Therapeutic 
indications 

For the symptomatic relief of colds, coughs, catarrh, sore
throats, influenza, 
catarrhal headache and nasal congestion. 

4.2 
Posology and method of administration 

For oropharyngeal use. 
Adults and children aged 7 and over: Dissolve 1 pastille
slowly in the mouth 
when required. 
Do not take more than 8 pastilles in any 24-hour period. 
Not recommended for children under 7 years old. 

Page 2 of 5 
4.3 Contraindications 

Hypersensitivity to the active substances or to any of the
excipients. 

4.4 
Special warnings and precautions for use 

Patients with rare hereditary problems of fructose
intolerance, glucose-
galactose malabsorption or sucrase-isomaltase insufficiency should
not take 
this medicine. 
If symptoms worsen or do not improve after 7 days, a doctor should
be 
contacted. 

4.5 Interactions 
with 
other 
medicinal 
products and other forms of interaction 

No interaction studies have been performed. 

4.6 
Pregnancy and lactation 

There are no or limited amount of data from the use of Olbas
Pastilles in 
pregnant women. Animal studies are insufficient with respect
to reproductive 
toxicity. Olbas Pastilles should not be used during
pregnancy unless potential 
benefits outweigh any risks. 

It is unknown whether Olbas
Pastilles/